NCT03000309View on ClinicalTrials.gov

Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 29, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

April 25, 2018

Conditions
Plaque Psoriasis
Interventions
DRUG

Apremilast

Trial Locations (1)

40217

DermResearch, PLLC, Louisville

Sponsors

Collaborators (1)

Celgene
All Listed Sponsors
collaborator

Celgene

INDUSTRY

lead

Derm Research, PLLC

OTHER